The State of Modeling Preclinical Immuno-Oncology Pharmacology - Insights From Our Labs to Yours
Using Syngeneic Models for the Discovery of Combination Therapy Targets & Predictive Biomarkers of Immunotherapy Efficacy - Drug Discovery World (DDW)
Syngeneic Mouse Models
Preclinical models of immuno-oncology therapeutics
Webinar review: Patient-Derived Xenografts on Humanized Mice | Taconic Biosciences
IJMS | Free Full-Text | Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer
Syngeneic Studies | The Jackson Laboratory
Genetically Engineered or Syngeneic Mouse Models?
Figure 1 | Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology | SpringerLink
Syngeneic Tumor Model-based Drug Screening | Creative Bioarray
Frontiers | Recent Technological Advances in Using Mouse Models to Study Ovarian Cancer
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies - Annals of Oncology
Syngeneic Mouse Models - PharmaLegacy | Preclinical Pharmacology CRO
Syngeneic leukemia models using lentiviral transgenics | Cell Death & Disease
Quantifying spontaneous metastasis in a syngeneic mouse melanoma model using real time PCR - Analyst (RSC Publishing)
Syngeneic Tumor Models | Encyclopedia MDPI
MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis | PLOS ONE
Syngeneic Mouse Model Of Glioblastoma - by Explicyte Immuno-Oncology
Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports
MC38 Syngeneic Mouse Model - Altogen Labs
Syngeneic Mouse Models | Charles River
Syngeneic Tumor Mouse Models & Research Tools | Taconic Biosciences
Mouse syngeneic model of endometriosis and experimental design. | Download Scientific Diagram
Syngeneic Mouse Models | Charles River
Syngeneic Mouse Models and Humanized Immune-Checkpoint Mice - Biocytogen
Syngeneic Mouse Models | Oncology | genOway
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies | SpringerLink
Syngeneic Cell Lines Derived Tumor Models - Creative Biolabs
